{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:14:50Z","timestamp":1792239290307,"version":"4.4.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"18","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA133085"],"award-info":[{"award-number":["CA133085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA236436"],"award-info":[{"award-number":["CA236436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA125066"],"award-info":[{"award-number":["CA125066"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA227433"],"award-info":[{"award-number":["CA227433"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001364"],"award-info":[{"award-number":["CX001364"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,4,29]]},"DOI":"10.1038\/s41388-022-02283-0","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:04:43Z","timestamp":1648613083000},"page":"2651-2662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3823-9434","authenticated-orcid":false,"given":"Chunwan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-4076","authenticated-orcid":false,"given":"John D.","family":"Klement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolonda L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0354-8464","authenticated-orcid":false,"given":"Nicholas H.","family":"Oberlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-1127","authenticated-orcid":false,"given":"Cedric J.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron H.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5453-3668","authenticated-orcid":false,"given":"Mark W.","family":"Grinstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-3390","authenticated-orcid":false,"given":"Huidong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1965-7240","authenticated-orcid":false,"given":"Kebin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"2283_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"2283_CR2","doi-asserted-by":"crossref","unstructured":"Pathria G, Scott DA, Feng Y, Sang Lee J, Fujita Y, Zhang G, et al. Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. EMBO J. 2018;37:e99735.","DOI":"10.15252\/embj.201899735"},{"key":"2283_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"2283_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fendo.2020.00365","volume":"11","author":"T Ge","year":"2020","unstructured":"Ge T, Yang J, Zhou S, Wang Y, Li Y, Tong X. The role of the pentose phosphate pathway in diabetes and cancer. Front Endocrinol. 2020;11:365.","journal-title":"Front Endocrinol"},{"key":"2283_CR5","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1158\/0008-5472.CAN-17-4047","volume":"78","author":"S Wu","year":"2018","unstructured":"Wu S, Wang H, Li Y, Xie Y, Huang C, Zhao H, et al. Transcription factor YY1 promotes cell proliferation by directly activating the pentose phosphate pathway. Cancer Res. 2018;78:4549\u201362.","journal-title":"Cancer Res"},{"key":"2283_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.85","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zhang X, Li Y, Shao Y, Xiao J, Zhu G, et al. PAK4 regulates G6PD activity by p53 degradation involving colon cancer cell growth. Cell Death Dis. 2017;8:e2820.","journal-title":"Cell Death Dis"},{"key":"2283_CR7","doi-asserted-by":"crossref","unstructured":"Nakamura M, Nagase K, Yoshimitsu M, Magara T, Nojiri Y, Kato H, et al. Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma. J Immunother Cancer. 2020;8:e001679.","DOI":"10.1136\/jitc-2020-001679"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"eabk1023","DOI":"10.1126\/sciadv.abk1023","volume":"7","author":"H Ding","year":"2021","unstructured":"Ding H, Chen Z, Wu K, Huang SM, Wu WL, LeBoeuf SE, et al. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition. Sci Adv. 2021;7:eabk1023.","journal-title":"Sci Adv"},{"key":"2283_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fonc.2017.00087","volume":"7","author":"MA Kowalik","year":"2017","unstructured":"Kowalik MA, Columbano A, Perra A. Emerging role of the pentose phosphate pathway in hepatocellular carcinoma. Front Oncol. 2017;7:87.","journal-title":"Front Oncol"},{"key":"2283_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbapap.2018.05.005","volume":"1867","author":"R Nagashio","year":"2019","unstructured":"Nagashio R, Oikawa S, Yanagita K, Hagiuda D, Kuchitsu Y, Igawa S, et al. Prognostic significance of G6PD expression and localization in lung adenocarcinoma. Biochim Biophys Acta Proteins Proteom. 2019;1867:38\u201346.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"2283_CR11","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1158\/0008-5472.CAN-19-2486","volume":"80","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich JM, Esposito M, Chen Z, Wang JZ, Bhatt V, Lan T, et al. Glucose-6-phosphate dehydrogenase is not essential for K-RAS-driven tumor growth or metastasis. Cancer Res. 2020;80:3820\u20139.","journal-title":"Cancer Res"},{"key":"2283_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s42255-019-0043-x","volume":"1","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Z, Hoshino A, Zheng HD, Morley M, Arany Z, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nat Metab. 2019;1:404\u201315.","journal-title":"Nat Metab"},{"key":"2283_CR13","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1021\/acschemneuro.8b00644","volume":"10","author":"B Liu","year":"2019","unstructured":"Liu B, Bai W, Ou G, Zhang J. Cdh1-mediated metabolic switch from pentose phosphate pathway to glycolysis contributes to sevoflurane-induced neuronal apoptosis in developing brain. ACS Chem Neurosci. 2019;10:2332\u201344.","journal-title":"ACS Chem Neurosci"},{"key":"2283_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ja.2012.69","volume":"65","author":"M Figueroa","year":"2012","unstructured":"Figueroa M, Graf TN, Ayers S, Adcock AF, Kroll DJ, Yang J, et al. Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae. J Antibiot. 2012;65:559\u201364.","journal-title":"J Antibiot"},{"key":"2283_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10295-018-2083-8","volume":"45","author":"CSM Amrine","year":"2018","unstructured":"Amrine CSM, Raja HA, Darveaux BA, Pearce CJ, Oberlies NH. Media studies to enhance the production of verticillins facilitated by in situ chemical analysis. J Ind Microbiol Biotechnol. 2018;45:1053\u201365.","journal-title":"J Ind Microbiol Biotechnol"},{"key":"2283_CR16","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/cmdc.201900341","volume":"14","author":"AG Raub","year":"2019","unstructured":"Raub AG, Hwang S, Horikoshi N, Cunningham AD, Rahighi S, Wakatsuki S, et al. Small-molecule activators of glucose-6-phosphate dehydrogenase (G6PD) bridging the dimer interface. ChemMedChem. 2019;14:1321\u20134.","journal-title":"ChemMedChem"},{"key":"2283_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06447-z","volume":"9","author":"S Hwang","year":"2018","unstructured":"Hwang S, Mruk K, Rahighi S, Raub AG, Chen CH, Dorn LE, et al. Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator. Nat Commun. 2018;9:4045.","journal-title":"Nat Commun"},{"key":"2283_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41589-020-0533-x","volume":"16","author":"JM Ghergurovich","year":"2020","unstructured":"Ghergurovich JM, Garcia-Canaveras JC, Wang J, Schmidt E, Zhang Z, TeSlaa T, et al. A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway. Nat Chem Biol. 2020;16:731\u20139.","journal-title":"Nat Chem Biol"},{"key":"2283_CR19","doi-asserted-by":"crossref","unstructured":"Lu C, Klement JD, Smith AD, Yang D, Waller JL, Browning DD, et al. p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy. J Immunother Cancer. 2020;8:e001365.","DOI":"10.1136\/jitc-2020-001365"},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-313X.2007.03387.x","volume":"53","author":"O Fiehn","year":"2008","unstructured":"Fiehn O, Wohlgemuth G, Scholz M, Kind T, Lee DY, Lu Y, et al. Quality control for plant metabolomics: reporting MSI-compliant studies. Plant J. 2008;53:691\u2013704.","journal-title":"Plant J"},{"key":"2283_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","volume":"18","author":"J Ding","year":"2013","unstructured":"Ding J, Li T, Wang X, Zhao E, Choi JH, Yang L, et al. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab. 2013;18:896\u2013907.","journal-title":"Cell Metab"},{"key":"2283_CR22","doi-asserted-by":"crossref","unstructured":"Lu C, Liu Z, Klement JD, Yang D, Merting AD, Poschel D, et al. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. J Immunother Cancer. 2021;9:e002624.","DOI":"10.1136\/jitc-2021-002624"},{"key":"2283_CR23","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4049\/jimmunol.1402243","volume":"195","author":"AV Paschall","year":"2015","unstructured":"Paschall AV, Yang D, Lu C, Choi JH, Li X, Liu F, et al. H3K9 trimethylation silences fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance. J Immunol. 2015;195:1868\u201382.","journal-title":"J Immunol"},{"key":"2283_CR24","doi-asserted-by":"publisher","first-page":"djw283","DOI":"10.1093\/jnci\/djw283","volume":"109","author":"C Lu","year":"2017","unstructured":"Lu C, Paschall AV, Shi H, Savage N, Waller JL, Sabbatini ME, et al. The MLL1-H3K4me3 axis-mediated PD-L1 expression and pancreatic cancer immune evasion. J Natl Cancer Inst. 2017;109:djw283.","journal-title":"J Natl Cancer Inst"},{"key":"2283_CR25","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.7150\/thno.42523","volume":"10","author":"D Ravindran Menon","year":"2020","unstructured":"Ravindran Menon D, Hammerlindl H, Torrano J, Schaider H, Fujita M. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer. Theranostics. 2020;10:6261\u201377.","journal-title":"Theranostics"},{"key":"2283_CR26","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2283_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/35065132","volume":"410","author":"M Lachner","year":"2001","unstructured":"Lachner M, O\u2019Carroll D, Rea S, Mechtler K, Jenuwein T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001;410:116\u201320.","journal-title":"Nature"},{"key":"2283_CR28","doi-asserted-by":"crossref","unstructured":"Lu C, Yang D, Klement JD, Colson YL, Oberlies NH, Pearce CJ, et al. G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes. J Immunother Cancer. 2022;10:e003543.","DOI":"10.1136\/jitc-2021-003543"},{"key":"2283_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.molcel.2009.12.017","volume":"37","author":"L Fritsch","year":"2010","unstructured":"Fritsch L, Robin P, Mathieu JR, Souidi M, Hinaux H, Rougeulle C, et al. A subset of the histone H3 lysine 9 methyltransferases Suv39h1, G9a, GLP, and SETDB1 participate in a multimeric complex. Mol Cell. 2010;37:46\u201356.","journal-title":"Mol Cell"},{"key":"2283_CR30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S1097-2765(03)00479-9","volume":"12","author":"JC Rice","year":"2003","unstructured":"Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, et al. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell. 2003;12:1591\u20138.","journal-title":"Mol Cell"},{"key":"2283_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nchembio.2008","volume":"12","author":"MM Muller","year":"2016","unstructured":"Muller MM, Fierz B, Bittova L, Liszczak G, Muir TW. A two-state activation mechanism controls the histone methyltransferase Suv39h1. Nat Chem Biol. 2016;12:188\u201393.","journal-title":"Nat Chem Biol"},{"key":"2283_CR32","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1158\/0008-5472.CAN-05-3575","volume":"66","author":"PH Abbosh","year":"2006","unstructured":"Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, et al. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Res. 2006;66:5582\u201391.","journal-title":"Cancer Res"},{"key":"2283_CR33","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-19-3837","volume":"80","author":"D Matei","year":"2020","unstructured":"Matei D, Nephew KP. Epigenetic attire in ovarian cancer: the emperor\u2019s new clothes. Cancer Res. 2020;80:3775\u201385.","journal-title":"Cancer Res"},{"key":"2283_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1126\/science.aau0583","volume":"363","author":"D Nicetto","year":"2019","unstructured":"Nicetto D, Donahue G, Jain T, Peng T, Sidoli S, Sheng L, et al. H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification. Science. 2019;363:294\u20137.","journal-title":"Science"},{"key":"2283_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/onc.2015.134","volume":"35","author":"MM Olcina","year":"2016","unstructured":"Olcina MM, Leszczynska KB, Senra JM, Isa NF, Harada H, Hammond EM. H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Oncogene. 2016;35:793\u20139.","journal-title":"Oncogene"},{"key":"2283_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1158\/1535-7163.MCT-19-0205","volume":"19","author":"A Salvi","year":"2020","unstructured":"Salvi A, Amrine CSM, Austin JR, Kilpatrick K, Russo A, Lantvit D, et al. Verticillin A causes apoptosis and reduces tumor burden in high-grade serous ovarian cancer by inducing DNA damage. Mol Cancer Ther. 2020;19:89\u2013100.","journal-title":"Mol Cancer Ther"},{"key":"2283_CR37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","volume":"119","author":"BB Aggarwal","year":"2012","unstructured":"Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012;119:651\u201365.","journal-title":"Blood"},{"key":"2283_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.537","volume":"5","author":"Y Gu","year":"2014","unstructured":"Gu Y, Bouwman P, Greco D, Saarela J, Yadav B, Jonkers J, et al. Suppression of BRCA1 sensitizes cells to proteasome inhibitors. Cell Death Dis. 2014;5:e1580.","journal-title":"Cell Death Dis"},{"key":"2283_CR39","doi-asserted-by":"crossref","unstructured":"Iurlaro R, Puschel F, Leon-Annicchiarico CL, O\u2019Connor H, Martin SJ, Palou-Gramon D, et al. Glucose deprivation induces ATF4-mediated apoptosis through TRAIL death receptors. Mol Cell Biol. 2017;37:e00479-16.","DOI":"10.1128\/MCB.00479-16"},{"key":"2283_CR40","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977\u201392.","journal-title":"Biochim Biophys Acta"},{"key":"2283_CR41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","volume":"120","author":"RS Balaban","year":"2005","unstructured":"Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483\u201395.","journal-title":"Cell"},{"key":"2283_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fimmu.2018.00202","volume":"9","author":"SJ Koo","year":"2018","unstructured":"Koo SJ, Szczesny B, Wan X, Putluri N, Garg NJ. Pentose phosphate shunt modulates reactive oxygen species and nitric oxide production controlling Trypanosoma cruzi in macrophages. Front Immunol. 2018;9:202.","journal-title":"Front Immunol"},{"key":"2283_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1659-1","volume":"16","author":"D Tu","year":"2019","unstructured":"Tu D, Gao Y, Yang R, Guan T, Hong JS, Gao HM. The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration. J Neuroinflammation. 2019;16:255.","journal-title":"J Neuroinflammation"},{"key":"2283_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"2283_CR45","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.celrep.2020.01.039","volume":"30","author":"N Oshima","year":"2020","unstructured":"Oshima N, Ishida R, Kishimoto S, Beebe K, Brender JR, Yamamoto K, et al. Dynamic imaging of LDH inhibition in tumors reveals rapid in vivo metabolic rewiring and vulnerability to combination therapy. Cell Rep. 2020;30:1798\u2013810 e1794.","journal-title":"Cell Rep"},{"key":"2283_CR46","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 2010;107:2037\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2283_CR47","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1158\/0008-5472.CAN-19-0217","volume":"79","author":"C Yeung","year":"2019","unstructured":"Yeung C, Gibson AE, Issaq SH, Oshima N, Baumgart JT, Edessa LD, et al. Targeting glycolysis through inhibition of lactate dehydrogenase impairs tumor growth in preclinical models of ewing sarcoma. Cancer Res. 2019;79:5060\u201373.","journal-title":"Cancer Res"},{"key":"2283_CR48","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.molcel.2012.09.025","volume":"48","author":"LA Sena","year":"2012","unstructured":"Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 2012;48:158\u201367.","journal-title":"Mol Cell"},{"key":"2283_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.192","volume":"8","author":"SL Jian","year":"2017","unstructured":"Jian SL, Chen WW, Su YC, Su YW, Chuang TH, Hsu SC, et al. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Cell Death Dis. 2017;8:e2779.","journal-title":"Cell Death Dis"},{"key":"2283_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2015.06.017","volume":"59","author":"A Kuehne","year":"2015","unstructured":"Kuehne A, Emmert H, Soehle J, Winnefeld M, Fischer F, Wenck H, et al. Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Mol Cell. 2015;59:359\u201371.","journal-title":"Mol Cell"},{"key":"2283_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.molcel.2015.08.002","volume":"59","author":"TP Dick","year":"2015","unstructured":"Dick TP, Ralser M. Metabolic remodeling in times of stress: who shoots faster than his shadow? Mol Cell. 2015;59:519\u201321.","journal-title":"Mol Cell"},{"key":"2283_CR52","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s42255-020-00330-2","volume":"3","author":"W Li","year":"2021","unstructured":"Li W, Kou J, Qin J, Li L, Zhang Z, Pan Y, et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat Metab. 2021;3:75\u201389.","journal-title":"Nat Metab"},{"key":"2283_CR53","doi-asserted-by":"crossref","unstructured":"Monteiro-Reis S, Lameirinhas A, Miranda-Goncalves V, Felizardo D, Dias PC, Oliveira J, et al. Sirtuins\u2019 deregulation in bladder cancer: SIRT7 is implicated in tumor progression through epithelial to mesenchymal transition promotion. Cancers. 2020;12:1066.","DOI":"10.3390\/cancers12051066"},{"key":"2283_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01052-2","volume":"13","author":"J Stomper","year":"2021","unstructured":"Stomper J, Meier R, Ma T, Pfeifer D, Ihorst G, Blagitko-Dorfs N, et al. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML\/MDS patients. Clin Epigenet. 2021;13:77.","journal-title":"Clin Epigenet"},{"key":"2283_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.molcel.2013.12.005","volume":"53","author":"C Mozzetta","year":"2014","unstructured":"Mozzetta C, Pontis J, Fritsch L, Robin P, Portoso M, Proux C, et al. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell. 2014;53:277\u201389.","journal-title":"Mol Cell"},{"key":"2283_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.gdata.2015.05.043","volume":"5","author":"AV Paschall","year":"2015","unstructured":"Paschall AV, Liu K. Epigenetic regulation of apoptosis and cell cycle regulatory genes in human colon carcinoma cells. Genom Data. 2015;5:189\u201391.","journal-title":"Genom Data"},{"key":"2283_CR57","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.canlet.2020.02.004","volume":"476","author":"C Lu","year":"2020","unstructured":"Lu C, Klement JD, Yang D, Albers T, Lebedyeva IO, Waller JL, et al. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth. Cancer Lett. 2020;476:87\u201396.","journal-title":"Cancer Lett"},{"key":"2283_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10585-019-09967-0","volume":"36","author":"D Williams","year":"2019","unstructured":"Williams D, Fingleton B. Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis. Clin Exp Metastasis. 2019;36:211\u201324.","journal-title":"Clin Exp Metastasis"},{"key":"2283_CR59","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1038\/onc.2016.485","volume":"36","author":"CC Wong","year":"2017","unstructured":"Wong CC, Qian Y, Yu J. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches. Oncogene. 2017;36:3359\u201374.","journal-title":"Oncogene"},{"key":"2283_CR60","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald OG, Li X, Saunders T, Tryggvadottir R, Mentch SJ, Warmoes MO, et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat Genet. 2017;49:367\u201376.","journal-title":"Nat Genet"},{"key":"2283_CR61","doi-asserted-by":"publisher","first-page":"102265","DOI":"10.1016\/j.ctrv.2021.102265","volume":"100","author":"W Cui","year":"2021","unstructured":"Cui W, Popat S. Pleural mesothelioma (PM)\u2014the status of systemic therapy. Cancer Treat Rev. 2021;100:102265.","journal-title":"Cancer Treat Rev"},{"key":"2283_CR62","doi-asserted-by":"publisher","first-page":"678447","DOI":"10.3389\/fonc.2021.678447","volume":"11","author":"G Pinton","year":"2021","unstructured":"Pinton G, Wang Z, Balzano C, Missaglia S, Tavian D, Boldorini R, et al. CDKN2A determines mesothelioma cell fate to EZH2 inhibition. Front Oncol. 2021;11:678447.","journal-title":"Front Oncol"},{"key":"2283_CR63","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jtho.2018.02.021","volume":"13","author":"AJ McCambridge","year":"2018","unstructured":"McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, et al. Progress in the management of malignant pleural mesothelioma in 2017. J Thorac Oncol. 2018;13:606\u201323.","journal-title":"J Thorac Oncol"},{"key":"2283_CR64","doi-asserted-by":"crossref","unstructured":"Hotta K, Fujimoto N. Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma. J Immunother Cancer. 2020;8:e000461.","DOI":"10.1136\/jitc-2019-000461"},{"key":"2283_CR65","doi-asserted-by":"crossref","unstructured":"Nakajima EC, Vellanki PJ, Larkins E, Chatterjee S, Mishra-Kalyani PS, Bi Y, et al. FDA approval summary: nivolumab in combination with ipilimumab for the treatment of unresectable malignant pleural mesothelioma. Clin Cancer Res. 2021;28:446\u201351.","DOI":"10.1158\/1078-0432.CCR-21-1466"},{"key":"2283_CR66","doi-asserted-by":"crossref","unstructured":"Lemoine J, Ruella M, Houot R. Overcoming intrinsic resistance of cancer cells to CAR T-cell killing. Clin Cancer Res. 2021;27:6298\u2013306.","DOI":"10.1158\/1078-0432.CCR-21-1559"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02283-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02283-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T11:10:57Z","timestamp":1651230657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02283-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":66,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,4,29]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02283-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"21 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AHC, MWG, and NHO have ownership interest in Ionic Pharmaceuticals, LLC. KL has an ownership interest in CheMedImmune Inc. NHO is a member of the Scientific Advisory Board of Mycosynthetix, Inc. CJP has an ownership interest in Mycosynthetix, Inc. Other authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}